Clinical trials
Recruiting Phase 2 Down Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aelis Farma | 1 |
| Alnylam Pharmaceuticals | 1 |
| Brigham and Women's Hospital | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| National Cancer Institute (NCI) | 1 |
| Ohio State University | 1 |
| Stefano Vicari | 1 |
| University of Colorado, Denver | 1 |
| Vanderbilt University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Down Syndrome | 9 |
| Alopecia Areata | 1 |
| Alzheimer Disease | 1 |
| Burkitt Lymphoma | 1 |
| Cognitive Dysfunction | 1 |
| Dermatitis, Atopic | 1 |
| Sleep Apnea, Obstructive | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.